{"latest_checked": "2026-07-29T22:11:07.860409+00:00", "coverage_count": 5079, "recent_count": 35, "transaction_limit": 160, "filters": {"q": "", "ticker": "IMVT", "sector": "", "industry": "", "side": "", "start": "2026-06-15", "end": "2026-07-30"}, "summary": {"total": 35, "acquisition_count": 6, "disposal_count": 29, "acquisition_value": 1800898.28, "acquisition_value_label": "$1.8M", "disposal_value": 7602083.98, "disposal_value_label": "$7.6M", "net_value": -5801185.7, "net_value_label": "$-5.8M", "flow_tone": "negative", "largest_value_label": "$3.3M", "top_sector": "Healthcare", "window_label": "15 Jun 2026 to 30 Jul 2026"}, "charts": {"sectors": [{"ticker__sector": "Healthcare", "count": 35, "value": "9402982.2600", "bar_width": 100.0, "sector_slug": "healthcare", "value_label": "$9.4M"}], "days": [{"transaction_date": "2026-06-15", "acquisitions": 1, "disposals": 2, "total": 3, "bar_width": 21.4}, {"transaction_date": "2026-06-18", "acquisitions": 0, "disposals": 1, "total": 1, "bar_width": 7.1}, {"transaction_date": "2026-06-26", "acquisitions": 3, "disposals": 11, "total": 14, "bar_width": 100.0}, {"transaction_date": "2026-07-01", "acquisitions": 1, "disposals": 2, "total": 3, "bar_width": 21.4}, {"transaction_date": "2026-07-02", "acquisitions": 0, "disposals": 1, "total": 1, "bar_width": 7.1}, {"transaction_date": "2026-07-08", "acquisitions": 0, "disposals": 8, "total": 8, "bar_width": 57.1}, {"transaction_date": "2026-07-23", "acquisitions": 0, "disposals": 2, "total": 2, "bar_width": 14.3}, {"transaction_date": "2026-07-24", "acquisitions": 1, "disposals": 2, "total": 3, "bar_width": 21.4}], "side_mix": {"acquisitions": 6, "disposals": 29, "acquisition_share": 17.1, "disposal_share": 82.9}}, "company_flows": [{"symbol": "IMVT", "name": "Immunovant\u00a0Inc", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-24", "acquisitions": 6, "disposals": 29, "acquired_value": 1800898.28, "acquired_value_label": "$1.8M", "disposed_value": 7602083.98, "disposed_value_label": "$7.6M", "net_value": -5801185.7, "net_value_label": "$-5.8M", "acquisition_share": 17.1, "disposal_share": 82.9, "detail_url": "https://sharemaestro.com/insider-activity/company/imvt/", "research_links": {"chart": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/", "report": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/report/", "factor": "/factors/ticker/5eec2eb7-c752-428d-aacf-90e20518de10/"}}], "company_overview": [{"symbol": "IMVT", "name": "Immunovant\u00a0Inc", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-24", "filings": 35, "acquisitions": 6, "disposals": 29, "acquired_value": 1800898.28, "acquired_value_label": "$1.8M", "disposed_value": 7602083.98, "disposed_value_label": "$7.6M", "net_value": -5801185.7, "net_value_label": "$-5.8M", "acquisition_share": 17.1, "disposal_share": 82.9, "tone": "Net disposal", "tone_class": "negative", "detail_url": "https://sharemaestro.com/insider-activity/company/imvt/", "research_links": {"chart": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/", "report": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/report/", "factor": "/factors/ticker/5eec2eb7-c752-428d-aacf-90e20518de10/"}}], "transactions": [{"symbol": "IMVT", "name": "Immunovant\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-24", "executive": "PANDE, ATUL", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 1500.0, "share_price": 39.8, "transaction_value": 59700.0, "fetched_at": "2026-07-28T22:10:50.133768+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imvt/", "research_links": {"chart": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/", "report": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/report/", "factor": "/factors/ticker/5eec2eb7-c752-428d-aacf-90e20518de10/"}}, {"symbol": "IMVT", "name": "Immunovant\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-24", "executive": "PANDE, ATUL", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 1500.0, "share_price": 8.43, "transaction_value": 12645.0, "fetched_at": "2026-07-28T22:10:50.136582+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imvt/", "research_links": {"chart": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/", "report": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/report/", "factor": "/factors/ticker/5eec2eb7-c752-428d-aacf-90e20518de10/"}}, {"symbol": "IMVT", "name": "Immunovant\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-24", "executive": "PANDE, ATUL", "executive_title": "Director", "security_type": "Stock Option (right to buy)", "side_code": "D", "side": "Disposal", "shares": 1500.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-28T22:10:50.138329+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imvt/", "research_links": {"chart": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/", "report": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/report/", "factor": "/factors/ticker/5eec2eb7-c752-428d-aacf-90e20518de10/"}}, {"symbol": "IMVT", "name": "Immunovant\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-23", "executive": "GIRAO, TIAGO", "executive_title": "Chief Financial Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 6798.0, "share_price": 38.69, "transaction_value": 263014.62, "fetched_at": "2026-07-28T22:10:50.139935+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imvt/", "research_links": {"chart": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/", "report": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/report/", "factor": "/factors/ticker/5eec2eb7-c752-428d-aacf-90e20518de10/"}}, {"symbol": "IMVT", "name": "Immunovant\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-23", "executive": "STOUT, JAY S", "executive_title": "Chief Technology Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 2857.0, "share_price": 38.69, "transaction_value": 110537.33, "fetched_at": "2026-07-28T22:10:50.141405+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imvt/", "research_links": {"chart": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/", "report": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/report/", "factor": "/factors/ticker/5eec2eb7-c752-428d-aacf-90e20518de10/"}}, {"symbol": "IMVT", "name": "Immunovant\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-08", "executive": "GLORIA, MELANIE", "executive_title": "Chief Operating Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 1930.0, "share_price": 39.53, "transaction_value": 76292.9, "fetched_at": "2026-07-28T22:10:50.144754+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imvt/", "research_links": {"chart": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/", "report": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/report/", "factor": "/factors/ticker/5eec2eb7-c752-428d-aacf-90e20518de10/"}}, {"symbol": "IMVT", "name": "Immunovant\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-08", "executive": "STOUT, JAY S", "executive_title": "Chief Technology Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 1906.0, "share_price": 39.53, "transaction_value": 75344.18, "fetched_at": "2026-07-28T22:10:50.148161+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imvt/", "research_links": {"chart": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/", "report": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/report/", "factor": "/factors/ticker/5eec2eb7-c752-428d-aacf-90e20518de10/"}}, {"symbol": "IMVT", "name": "Immunovant\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-08", "executive": "STOUT, JAY S", "executive_title": "Chief Technology Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 1399.0, "share_price": 39.53, "transaction_value": 55302.47, "fetched_at": "2026-07-28T22:10:50.155022+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imvt/", "research_links": {"chart": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/", "report": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/report/", "factor": "/factors/ticker/5eec2eb7-c752-428d-aacf-90e20518de10/"}}, {"symbol": "IMVT", "name": "Immunovant\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-08", "executive": "VAN, TUYL CHRISTOPHER", "executive_title": "Chief Legal Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 1143.0, "share_price": 39.53, "transaction_value": 45182.79, "fetched_at": "2026-07-28T22:10:50.151589+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imvt/", "research_links": {"chart": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/", "report": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/report/", "factor": "/factors/ticker/5eec2eb7-c752-428d-aacf-90e20518de10/"}}, {"symbol": "IMVT", "name": "Immunovant\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-08", "executive": "GLORIA, MELANIE", "executive_title": "Chief Operating Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 106.0, "share_price": 39.99, "transaction_value": 4238.94, "fetched_at": "2026-07-28T22:10:50.143156+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imvt/", "research_links": {"chart": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/", "report": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/report/", "factor": "/factors/ticker/5eec2eb7-c752-428d-aacf-90e20518de10/"}}, {"symbol": "IMVT", "name": "Immunovant\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-08", "executive": "STOUT, JAY S", "executive_title": "Chief Technology Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 105.0, "share_price": 39.99, "transaction_value": 4198.95, "fetched_at": "2026-07-28T22:10:50.146456+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imvt/", "research_links": {"chart": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/", "report": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/report/", "factor": "/factors/ticker/5eec2eb7-c752-428d-aacf-90e20518de10/"}}, {"symbol": "IMVT", "name": "Immunovant\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-08", "executive": "STOUT, JAY S", "executive_title": "Chief Technology Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 77.0, "share_price": 39.99, "transaction_value": 3079.23, "fetched_at": "2026-07-28T22:10:50.153269+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imvt/", "research_links": {"chart": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/", "report": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/report/", "factor": "/factors/ticker/5eec2eb7-c752-428d-aacf-90e20518de10/"}}, {"symbol": "IMVT", "name": "Immunovant\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-08", "executive": "VAN, TUYL CHRISTOPHER", "executive_title": "Chief Legal Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 63.0, "share_price": 39.99, "transaction_value": 2519.37, "fetched_at": "2026-07-28T22:10:50.149734+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imvt/", "research_links": {"chart": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/", "report": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/report/", "factor": "/factors/ticker/5eec2eb7-c752-428d-aacf-90e20518de10/"}}, {"symbol": "IMVT", "name": "Immunovant\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-02", "executive": "VENKER, ERIC", "executive_title": "Director, Chief Executive Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 3092.0, "share_price": 38.48, "transaction_value": 118980.16, "fetched_at": "2026-07-23T21:50:01.471508+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imvt/", "research_links": {"chart": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/", "report": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/report/", "factor": "/factors/ticker/5eec2eb7-c752-428d-aacf-90e20518de10/"}}, {"symbol": "IMVT", "name": "Immunovant\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "VENKER, ERIC", "executive_title": "Director, Chief Executive Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 86629.0, "share_price": 38.14, "transaction_value": 3304030.06, "fetched_at": "2026-07-21T22:06:13.554940+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imvt/", "research_links": {"chart": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/", "report": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/report/", "factor": "/factors/ticker/5eec2eb7-c752-428d-aacf-90e20518de10/"}}, {"symbol": "IMVT", "name": "Immunovant\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "VENKER, ERIC", "executive_title": "Director, Chief Executive Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 92188.0, "share_price": 14.46, "transaction_value": 1333038.48, "fetched_at": "2026-07-21T22:06:13.556683+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imvt/", "research_links": {"chart": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/", "report": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/report/", "factor": "/factors/ticker/5eec2eb7-c752-428d-aacf-90e20518de10/"}}, {"symbol": "IMVT", "name": "Immunovant\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "VENKER, ERIC", "executive_title": "Director, Chief Executive Officer", "security_type": "Capped Value Appreciation Rights", "side_code": "D", "side": "Disposal", "shares": 92188.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T22:06:13.553170+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imvt/", "research_links": {"chart": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/", "report": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/report/", "factor": "/factors/ticker/5eec2eb7-c752-428d-aacf-90e20518de10/"}}, {"symbol": "IMVT", "name": "Immunovant\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-26", "executive": "STOUT, JAY S", "executive_title": "Chief Technology Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 33277.0, "share_price": 38.18, "transaction_value": 1270515.86, "fetched_at": "2026-07-16T21:45:32.094757+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imvt/", "research_links": {"chart": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/", "report": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/report/", "factor": "/factors/ticker/5eec2eb7-c752-428d-aacf-90e20518de10/"}}, {"symbol": "IMVT", "name": "Immunovant\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-26", "executive": "VAN, TUYL CHRISTOPHER", "executive_title": "Chief Legal Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 14982.0, "share_price": 38.19, "transaction_value": 572162.58, "fetched_at": "2026-07-16T21:45:32.120116+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imvt/", "research_links": {"chart": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/", "report": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/report/", "factor": "/factors/ticker/5eec2eb7-c752-428d-aacf-90e20518de10/"}}, {"symbol": "IMVT", "name": "Immunovant\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-26", "executive": "GLORIA, MELANIE", "executive_title": "Chief Operating Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 14748.0, "share_price": 38.18, "transaction_value": 563078.64, "fetched_at": "2026-07-16T21:45:32.097734+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imvt/", "research_links": {"chart": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/", "report": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/report/", "factor": "/factors/ticker/5eec2eb7-c752-428d-aacf-90e20518de10/"}}, {"symbol": "IMVT", "name": "Immunovant\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-26", "executive": "GIRAO, TIAGO", "executive_title": "Chief Financial Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 10000.0, "share_price": 38.46, "transaction_value": 384600.0, "fetched_at": "2026-07-16T21:45:32.111418+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imvt/", "research_links": {"chart": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/", "report": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/report/", "factor": "/factors/ticker/5eec2eb7-c752-428d-aacf-90e20518de10/"}}, {"symbol": "IMVT", "name": "Immunovant\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-26", "executive": "VAN, TUYL CHRISTOPHER", "executive_title": "Chief Legal Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 17824.0, "share_price": 15.2, "transaction_value": 270924.8, "fetched_at": "2026-07-16T21:45:32.122380+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imvt/", "research_links": {"chart": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/", "report": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/report/", "factor": "/factors/ticker/5eec2eb7-c752-428d-aacf-90e20518de10/"}}, {"symbol": "IMVT", "name": "Immunovant\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-26", "executive": "STOUT, JAY S", "executive_title": "Chief Technology Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 6723.0, "share_price": 38.94, "transaction_value": 261793.62, "fetched_at": "2026-07-16T21:45:32.124630+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imvt/", "research_links": {"chart": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/", "report": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/report/", "factor": "/factors/ticker/5eec2eb7-c752-428d-aacf-90e20518de10/"}}, {"symbol": "IMVT", "name": "Immunovant\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-26", "executive": "GIRAO, TIAGO", "executive_title": "Chief Financial Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 10000.0, "share_price": 15.9, "transaction_value": 159000.0, "fetched_at": "2026-07-16T21:45:32.113719+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imvt/", "research_links": {"chart": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/", "report": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/report/", "factor": "/factors/ticker/5eec2eb7-c752-428d-aacf-90e20518de10/"}}, {"symbol": "IMVT", "name": "Immunovant\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-26", "executive": "GLORIA, MELANIE", "executive_title": "Chief Operating Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 2966.0, "share_price": 38.95, "transaction_value": 115525.7, "fetched_at": "2026-07-16T21:45:32.100333+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imvt/", "research_links": {"chart": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/", "report": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/report/", "factor": "/factors/ticker/5eec2eb7-c752-428d-aacf-90e20518de10/"}}, {"symbol": "IMVT", "name": "Immunovant\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-26", "executive": "VAN, TUYL CHRISTOPHER", "executive_title": "Chief Legal Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 2842.0, "share_price": 38.96, "transaction_value": 110724.32, "fetched_at": "2026-07-16T21:45:32.118031+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imvt/", "research_links": {"chart": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/", "report": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/report/", "factor": "/factors/ticker/5eec2eb7-c752-428d-aacf-90e20518de10/"}}, {"symbol": "IMVT", "name": "Immunovant\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-26", "executive": "PANDE, ATUL", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 1500.0, "share_price": 38.01, "transaction_value": 57015.0, "fetched_at": "2026-07-16T21:45:32.105189+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imvt/", "research_links": {"chart": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/", "report": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/report/", "factor": "/factors/ticker/5eec2eb7-c752-428d-aacf-90e20518de10/"}}, {"symbol": "IMVT", "name": "Immunovant\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-26", "executive": "PANDE, ATUL", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 1500.0, "share_price": 8.43, "transaction_value": 12645.0, "fetched_at": "2026-07-16T21:45:32.107499+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imvt/", "research_links": {"chart": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/", "report": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/report/", "factor": "/factors/ticker/5eec2eb7-c752-428d-aacf-90e20518de10/"}}, {"symbol": "IMVT", "name": "Immunovant\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-26", "executive": "GIRAO, TIAGO", "executive_title": "Chief Financial Officer", "security_type": "Stock Option (right to buy)", "side_code": "D", "side": "Disposal", "shares": 10000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-16T21:45:32.109473+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imvt/", "research_links": {"chart": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/", "report": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/report/", "factor": "/factors/ticker/5eec2eb7-c752-428d-aacf-90e20518de10/"}}, {"symbol": "IMVT", "name": "Immunovant\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-26", "executive": "PANDE, ATUL", "executive_title": "Director", "security_type": "Stock Option (right to buy)", "side_code": "D", "side": "Disposal", "shares": 1500.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-16T21:45:32.102885+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imvt/", "research_links": {"chart": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/", "report": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/report/", "factor": "/factors/ticker/5eec2eb7-c752-428d-aacf-90e20518de10/"}}, {"symbol": "IMVT", "name": "Immunovant\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-26", "executive": "VAN, TUYL CHRISTOPHER", "executive_title": "Chief Legal Officer", "security_type": "Stock Option (right to buy)", "side_code": "D", "side": "Disposal", "shares": 17824.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-16T21:45:32.116015+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imvt/", "research_links": {"chart": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/", "report": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/report/", "factor": "/factors/ticker/5eec2eb7-c752-428d-aacf-90e20518de10/"}}, {"symbol": "IMVT", "name": "Immunovant\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "VAN, TUYL CHRISTOPHER", "executive_title": "Chief Legal Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 2634.0, "share_price": 35.39, "transaction_value": 93217.26, "fetched_at": "2026-07-13T10:23:04.948251+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imvt/", "research_links": {"chart": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/", "report": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/report/", "factor": "/factors/ticker/5eec2eb7-c752-428d-aacf-90e20518de10/"}}, {"symbol": "IMVT", "name": "Immunovant\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-15", "executive": "PANDE, ATUL", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 1500.0, "share_price": 34.02, "transaction_value": 51030.0, "fetched_at": "2026-07-13T10:23:04.952372+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imvt/", "research_links": {"chart": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/", "report": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/report/", "factor": "/factors/ticker/5eec2eb7-c752-428d-aacf-90e20518de10/"}}, {"symbol": "IMVT", "name": "Immunovant\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-15", "executive": "PANDE, ATUL", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 1500.0, "share_price": 8.43, "transaction_value": 12645.0, "fetched_at": "2026-07-13T10:23:04.951015+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imvt/", "research_links": {"chart": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/", "report": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/report/", "factor": "/factors/ticker/5eec2eb7-c752-428d-aacf-90e20518de10/"}}, {"symbol": "IMVT", "name": "Immunovant\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-15", "executive": "PANDE, ATUL", "executive_title": "Director", "security_type": "Stock Option (right to buy)", "side_code": "D", "side": "Disposal", "shares": 1500.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T10:23:04.949501+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imvt/", "research_links": {"chart": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/", "report": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/report/", "factor": "/factors/ticker/5eec2eb7-c752-428d-aacf-90e20518de10/"}}], "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}